首页行业分类金融证券证券2023-03-21-国金证券-药明康德-业绩增长再创新高,2023稳健成长
PDF

2023-03-21-国金证券-药明康德-业绩增长再创新高,2023稳健成长

1*******04页806.8K

下载文档
/4
全屏查看
2023-03-21-国金证券-药明康德-业绩增长再创新高,2023稳健成长
还有 4 页未读 ,您可以 继续阅读 或 下载文档
报告派所有资源均由用户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
1、本文档共计 4 页,下载后文档不带水印,支持完整阅读内容或进行编辑。
2、当您下载文档后,并不意味着拥有了版权,文档仅供网友学习交流,不得用于其他商业用途。
3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!
4、本本所有内容不构成任何投资建议,不具有任何指导和买卖意见。
5、如文档内容存在违规,或者侵犯商业秘密、侵犯著作权等,请点击“违规举报”。
国金证券公司点评附录:三张报表预测摘要2020202120222023E2024E2025E2020202120222023E2024E2025E10,2378.2397,98617,5542261931,09438.5%7.0%25.5%28.4%应收款项3.7015,0076,2176.9588.73011.206-10,253-14,592-24,67-26,070-32,307-41,2012,68的5,9056,0909,62462063.7%62.7%61.9%61.26.4352.8354.1262.62928043.130毛利6,2828,31014,67816,02620,51326,59723.05921,98623,99733,23141,70055.05538.0%36.337.3%38.1%38.8%39.2%49.39.9%37.142.9%54.4%35-54-200-126-158-2037,4829.39210.15710.63110.93111.2310.20.20.3%9,21515,05922,58326,1712764227,696-588-699-732-842-1.056-1.35619927333.831.5%销售收入3.61.92.0%2.0%3.7475,0655,4186,5466.6236,456-1.839-2,203-2,826-3,961-5,08523,23233,14240,69344,29746,09846,2409.6线7.2%57.1%研发费用-3-942-1,614-1,68-2,113-2,7124.14.0%1,4072,6584,1024,1004,1504,2003,1274,4129,30610,00613,22417,241应付款项3,3965,2204,9915,3236.5778,39418.9%19.3%23.623.8%25.0%25.4%其他流动负债3.1177.2779,285-520-84248-199157,92012,98514,49915,28718,00421,879-0.60.5%279279279279-65-291-124-305,6523,3852,9852,9673.0273,03077018492093013.57316,37017,76418,53321,31125,2386061,35618865060060032.49438.49246.59058.60866.05175.57022.5%1.83.2%2,4422,9562,9612,96129612,9616,03810,65211,79114,67218,744未分配利润12,12619,13625,10932,55242,07120.5%26.4%28.0%27.8%27.6%225266337387437营业外收支-20-22-34-20-20-2055.1276.01610,61811,77114,65218,72420.4%26.327.0%28.0%27.7%27.6-880-1.716-1,766-2,198-2.8092020202120222023E2024E2025E11.4%16.2%15.0%15.015.0%2,9865,1368,90310,00512,45415,9151.2121.7243.3614.1885.356263950505013.30813.02215.73719.78622.29925.5122,96012,041.6201.5463.5783.5954.1505.20917.9%22.3%22.4%23.5%23.4%0.3370.3630.5171.3451.6762.14425%9.11s13.2418.92%16.99%18.7820.99%2020202120222023E2024E2025E6.3%9.25%13.62%12.84%14.13%15.665.1368.90310.00512.45414.935050501,2201,5452,2081,8081.8381.861主营业务收入增长率23.4671846.97%2547-313-1,517-1,079-1,243-1,240-1,25826.37%41.10%110.937.52%32.16线63-59472-767-1,09772.19%72.9112.95%24.60%27.90515,2158.32%19.09%17.35%19.84%13.25%15.37%资本开支-3.022-6,9349,668-3.624-3,330产力-5.8241,908-8021062063072.966.049.158.058.058.0711875865060060078.8107.485.687.087.087.090-2.110-45026.735.825.025.025.013,1621506,0450135.3143.0140.1144.8118.689.5-1,28429060其他-1.991-2,900-3.095-4.3755.212-6.598-1,2781,960-5,1526.052.5-37.550.3314.6-1,175.0-2.072-2155.02423.32%23.69%27.46%23.90%2427%24.92%来源:公司年报、国金证研究所2